James Trager, Chief Scientific Officer at Nkarta, Inc. (NKTX), sold 4,143 shares at $12.00 ($50K) on 2024-02-12, disclosed to the SEC on 2024-02-14.
Scheduled sale ($50k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NKTX | SELL | 2023-06-22 | $2K | — | Filing → |
| NKTX | SELL | 2023-01-18 | $6K | — | Filing → |
| NKTX | SELL | 2022-08-17 | $88K | — | Filing → |